NASDAQ: SANA - Sana Biotechnology, Inc.

Yield per half year: -55.45%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Sana Biotechnology, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Sana Biotechnology, Inc.

Sana Biotechnology, Inc., биотехнологическая компания, специализируется на использовании искусственных клеток в качестве лекарств. Компания разрабатывает платформы клеточной инженерии in vivo и ex vivo для различных терапевтических областей с неудовлетворенными потребностями в лечении, включая онкологию, диабет, расстройства центральной нервной системы, сердечно-сосудистые заболевания, генетические нарушения и другие. Sana Biotechnology, Inc. ранее была известна как FD Therapeutics, Inc. и сменила свое название на Sana Biotechnology, Inc. в сентябре 2018 года.

more details
Компания была зарегистрирована в 2018 году со штаб-квартирой в Сиэтле, штат Вашингтон.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-02-04
ISIN US7995661045
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.sana.com
Цена ао 2.7
Change price per day: +4.05% (2.59)
Change price per week: -12.78% (3.09)
Change price per month: -20.03% (3.37)
Change price per 3 month: +5.69% (2.55)
Change price per half year: -55.45% (6.05)
Change price per year: -74.74% (10.67)
Change price per 3 year: -61.72% (7.04)
Change price per 5 year: 0% (2.695)
Change price per 10 year: 0% (2.695)
Change price per year to date: +65.34% (1.63)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 3.08 5
P/E 0 0
EV/EBITDA -2.89 0
Total: 3.13

Efficiency

Title Value Grade
ROA, % -50.11 0
ROE, % -98.52 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.3529 10
Total: 9.4

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 81.15 9
Yield EPS, % 45.6 6
Total: 7
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
26.11.2024 26.11.2024 Hardy Nathan
Former CFO		 Purchase 2.5 229 018 91607 0 0.05 link
25.09.2024 26.09.2024 Mulligan Richard
Director		 Sale 3.89 583 500 150000 0 -0.08 link
24.09.2024 26.09.2024 Mulligan Richard
Director		 Sale 4.08 612 000 150000 0 -0.08 link
07.06.2023 08.06.2023 Flagship Ventures Fund V Gener
10% Owner		 Sale 6.24 1 248 000 200000 0 -0.11 link
06.06.2023 08.06.2023 Flagship Ventures Fund V Gener
10% Owner		 Sale 6.31 1 285 710 203758 0 -0.11 link
26.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Sale 6.23 510 860 82000 0 -0.04 link
25.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Sale 6.35 732 612 115372 0 -0.06 link
24.05.2023 26.05.2023 Flagship Ventures Fund V Gener
10% Owner		 Sale 6.57 2 285 510 347870 0 -0.18 link
21.03.2022 22.03.2022 Yang Patrick Y
Director		 Purchase 7.3 204 400 28000 0 0.01 link
09.09.2021 10.09.2021 Hordo Christian
EVP, Chief Business Officer		 Sale 25.01 1 617 420 64671 0 -0.03 link
03.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Sale 25 17 500 700 0 0 link
03.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Purchase 1.48 1 036 700 0 0 link
02.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Sale 25 198 950 7958 0 0 link
02.09.2021 07.09.2021 Hordo Christian
EVP, Chief Business Officer		 Purchase 1.48 9 706 6558 0 0 link

Institutions Volume Share, %
Flagship Pioneering Inc. 25001856 11.34
FMR, LLC 15751291 7.15
Canada Pension Plan Investment Board 10175000 4.62
Baillie Gifford and Company 10150017 4.6
Vanguard Group Inc 9797084 4.44
Blackrock Inc. 8469222 3.84
State Street Corporation 5908687 2.68
Price (T.Rowe) Associates Inc 3594025 1.63
Crestline Management, L.P. 3365624 1.53
Alphabet Inc. 2812500 1.28

ETF Share, % Profitability for 1 year, % Dividends, %
Global X Genomics & Biotechnology ETF 0.94439 2.58 0.15585
Virtus LifeSci Biotech Clinical Trials ETF 0.47073 63.04 0.33
WisdomTree BioRevolution Fund 0.44668 -4.69 0.78691
Direxion Daily S&P Biotech Bull 3x Shares 0.12306 4067.92 0.25924
Invesco Nasdaq Biotechnology ETF 0.09864 28.58 0.8565
Future Tech ETF 0.0919 426.34 0.8416
Principal Healthcare Innovators ETF 0.0919 618.5 0.8416
ProShares Ultra Nasdaq Biotechnology 0.06315 51.7 0.85651
Vanguard U.S. Momentum Factor ETF 0.06 30.05 1.05834
Vanguard Russell 2000 Growth ETF 0.06 23.05 0.60264
Goldman Sachs Innovate Equity ETF 0.05881 29.66 1.20987
iShares Russell 2000 Growth ETF 0.04172 38.04 0.6026
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.03662 24.75 1.59225
Vanguard Russell 2000 ETF 0.03 17.16 1.48801
FINEX EM EX-CHINDIA UCITS ETF 0.02 1.46
iShares Morningstar Small-Cap Growth ETF 0.01678 587.89 0.72598
iShares Morningstar Small-Cap Growth ETF 0.01678 33.63 0.72598
Schwab U.S. Small-Cap ETF 0.01263 17.47 1.51433
ProShares UltraPro Russell2000 0.01214 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.01096 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.01096 30.1 1.60498
Fidelity MSCI Health Care Index ETF 0.00868 3 1.46057
Humankind US Stock ETF 0.00834 18.81 1.99919
iShares Morningstar Small Cap Value ETF 0.00549 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.00549 201.65 2.50476
ProShares Hedge Replication ETF 0.00346 5.92 1.47892
SPDR Portfolio MSCI Global Stock Market ETF 0.00328 17.99 2.19607
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00326 21.94 1.69572
Dimensional U.S. Core Equity 2 ETF 0.00322 30.76 1.47098
Dimensional US Core Equity Market ETF 0.0017 30.98 1.40618
iShares Russell 3000 ETF 0.0014 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00087 24.86 1.43354
Dimensional U.S. Equity ETF 0.00085 31.53 1.3557
Avantis U.S. Equity ETF 0.00014 23.04 1.59151
Vanguard ESG U.S. Stock ETF 0 23.54 1.26927
Vanguard Russell 3000 ETF 0 31.87 1.43817



Head Job title Payment Year of birth
Mr. Nathan Hardy M.B.A. Executive VP & CFO 683.49k 1976 (49 years)
Dr. Edward Rebar Ph.D. Head of Cell Engineering N/A 1968 (57 years)
Ms. Robin Andrulevich Executive VP & Chief People Officer N/A 1966 (59 years)
Dr. Steven D. Harr M.D. President, CEO & Director 1.04M 1970 (55 years)
Mr. Paul Brunetta M.D. Senior VP and Head of Clinical & Translational Science N/A
Mr. Bernard J. Cassidy J.D. Executive VP, General Counsel & Corporate Secretary 491.39k 1955 (70 years)
Mr. Christian Hordo M.B.A. Executive VP & Chief Business Officer 485.03k 1983 (42 years)
Dr. Sonja Schrepfer M.D., Ph.D. Senior VP & Head of Hypoimmune Platform N/A 1975 (50 years)
Mr. Snehal Patel Senior VP & Chief Technical Officer
Dr. Dhavalkumar D. Patel M.D., Ph.D. Executive VP & Chief Scientific Officer 1961 (64 years)

Address: United States, Seattle, WA , 188 East Blaine Street - open in Google maps, open in Yandex maps
Website: https://www.sana.com